Vantage Oncology, Inc. (extinct)

Vantage Oncology, Inc. (extinct)

Vantage Oncology, Inc. (extinct)

Overview
Date Founded

2002

Headquarters

1500 Rosecrans Avenue,Suite 400,Manhattan Beach, CA 90266

Type of Company

Private

Industries

Hospitals & Patient Services
Medical Support Services

Company Description

Vantage owns and operates oncology centers. Its network of affiliated andpartnered medical groups provide critical oncology services.It treats cancer by creating an environment of wellness surrounding the patient with exceptional medical professionals, vast clinical expertise and technical resources. It becomes part of every community it serves and work with other organizations to bring awareness and education to those affected by cancer. It is making a difference and proving it every day.Its partnership model and its focus on the patient experience, outcomes, quality of care andadvanced technologies, have been the critical elements of its success and growth. Treatment centers that are part of the Vantage network receive extensive management services, including administrative support, capital improvements and technology acquisition. It also provides strategic planning, information systems consulting, accounting resources, managed care contracting, human resources and marketing services. By allowing them to manage the day-to-day operations and other aspects of equipping and staffing a treatment center, it enables physicians to focus on patient care.It is proud to merge with the physicians and staff of RC Cancer Centers. With years of experience, RC Cancer Centers, a leading radiation therapy organization, is committed to providing personalized patient care using the latest technology in warm and inviting centers of excellence.It is expanding into additional markets. Whether an acquisition, joint venture or new center development, its experienced management team is ready to help customers move forward. Contact Vantage today and leverage the strength of its clinical, financial and managerial resources.

Contact Data
Trying to get in touch with decision makers at Vantage Oncology, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Paths to Vantage Oncology, Inc.
Potential Connections via
Relationship Science
You
Vantage Oncology, Inc.
Recent Transactions
Details Hidden

Oak Hill Capital Management LLC, Physician Oncology Services Management Co. LLC purchase Vantage Oncology, Inc.

Details Hidden

Vantage Oncology, Inc. purchases Crookshank Cancer Center

Details Hidden

Vantage Oncology, Inc. purchases Eastgate Cancer Center

Transaction Advisors
Legal Advisor

Advised onOak Hill Capital Management LLC, Physician Oncology Services Management Co. LLC purchase Vantage Oncology, Inc.

Investment Advisor

Advised onOak Hill Capital Management LLC, Physician Oncology Services Management Co. LLC purchase Vantage Oncology, Inc.

Legal Advisor

Advised onOak Hill Capital Management LLC, Physician Oncology Services Management Co. LLC purchase Vantage Oncology, Inc.

Advisors & Consultants
Legal Advisor

Partner at DLA Piper

Investors
Details Hidden

HLM Venture Partners focuses on investments in the healthcare sector. The firm targets companies operating in the fields of health care information technology & tech enabled health care services, medical devices and diagnostics. HLM provides financing for early to growth stage capital requirements. They both lead financings & participate as co-investors, and they participate in small financings all the way up to larger pre-IPO rounds and buyouts.

Details Hidden

CCP Equity Partners focuses on investments in North American financial services and healthcare companies. They look for companies with the potential for exceptional growth that can develop sustainable competitive advantages in well-defined market niches or sectors. The firm is particularly interested in companies that are leveraging innovative business models and specialization to create demonstrable scale advantages. CCP Equity Partners is also interested in companies that are utilizing applied technology and process advances that can change their business paradigms and in companies that are employing unique business methods and structural advantages that drive operating and capital efficiencies. CCP Equity Partners primarily makes growth equity investments in companies with revenues of $5 million to $100 million. Companies should have proven business models that are profitable or have the near-term potential to become. The firm targets returns of 2.5x to 5x with a focus on preservation of capital. Investments range from $5 million to $20 million over the life of an investment. CCP Equity Partners typically acts as a lead or co-investor.

Details Hidden

New Enterprise Associates (NEA) focuses on investments in the technology and healthcare sectors. The firm's investment strategy spans all stages of a company's growth, from seeding innovations in emerging markets to funding early-stage companies in high-growth markets to fueling the growth of market leaders. NEA actively invests in emerging markets, with emphasis on India and China.NEA's investments in the healthcare sector focus on companies that address unmet or underserved clinical needs and that combine improved clinical outcomes with lower costs to the market. The firm targets three areas including biopharmaceuticals, medical devices and healthcare services. The firm has a history of partnering with companies that have pioneered transformative innovations in healthcare, such as balloon angioplasty and laparoscopic surgeryWithin the technology sector, NEA focuses on investments in the electronics, consumer technology, enterprise mobility, virtualization, tech-enabled services, SaaS and cloud computing industries.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Vantage Oncology, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Vantage Oncology, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Vantage Oncology, Inc..